Type
Article
Titre
Regulatory review time and post-market safety events for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional study
Auteur(s)
ZEITOUN Jean-David - Service de Gastroentérologie et nutrition (Auteur)
LEFÈVRE Jérémie H. - Hôpital Beaujon (Auteur)
DOWNING Nicholas - Brigham and Women's Hospital (Boston) (Auteur)
BERGERON Henri - Centre de sociologie des organisations (Auteur)
ROSS Joseph S. - Yale School of Medicine (Auteur)
Volume
80
Numéro
4
Pages
716 - 725 p.
DOI
10.1111/bcp.12643
Mots clés
European Medicines Agency, drug approval, government regulation
Résumé
EN
Regulatory review time has been associated with post-market medication safety issues in the United States. Our objective was to evaluate whether regulatory review time and near deadline approval are associated with post-market safety events (PMSEs) for novel medicines approved by the European Medicines Agency (EMA).
CITATION BIBLIOGRAPHIQUE
EXPORT